U.S. Food & Drug Administration
Nearly 2,000 Drug Plants are Overdue for FDA Checks After COVID Delays, AP Finds
Food and Drug Administration data shows that agency staffers have not returned to roughly 2,000 pharmaceutical manufacturing firms to conduct surveillance inspections since before the pandemic, raising the risks of contamination and other issues in drugs used by millions of Americans. read more >
by Associated Press -
FDA Approves Updated COVID-19 Vaccines
With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its modified vaccine version to be available a little later. read more >
by Associated Press -
After recalls and infections, experts say safer eyedrops will require new FDA powers
An October recall of two dozen eyedrop brands came after FDA staff found cracked floors, barefoot workers and other unsanitary conditions at a Mumbai plant that supplied products to CVS, Walmart and other major retailers. read more >
by Associated Press -
FDA Says Fake Ozempic Shots are Being Sold Through Some Legitimate Sources
They do not yet have information about the drugs' identity, quality or safety, according to a statement. read more >
by Associated Press -
FDA Panel Backs Over-The-Counter Sales of Birth Control Pill
The panel of FDA advisers voted unanimously in favor of drugmaker Perrigo's request to sell its once-a-day medication on store shelves alongside eye drops and allergy pills. read more >
by Associated Press -
Drug for Rare Form of Lou Gehrig’s Disease OK’d by FDA
It's the first drug for an inherited form of ALS, or amyotrophic lateral sclerosis, a deadly disease that destroys nerve cells needed for basic functions like walking, talking and swallowing. read more >
by Associated Press -
Supreme Court Preserves Access to Abortion Pill for Now
The justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone. They are appealing a lower court ruling that would roll back Food and Drug Administration approval of mifepristone. read more >
by Associated Press -
High Court Temporarily Blocks Restrictions on Abortion Pill
The court finds itself immersed in a new fight involving abortion less than a year after conservative justices reversed Roe v. Wade and allowed more than a dozen states to effectively ban abortion outright. read more >
by Associated Press -
FDA Forces Unproven Premature Birth Drug Makena Off Market
The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. read more >
Eyedrops Maker Couldn’t Ensure Factory Was Sterile, FDA Says
Global Pharma Healthcare's eyedrops have been linked to 68 bacterial infections in the U.S., including three deaths and eight cases of vision loss. read more >
When Will Medicare Cover Medical Marijuana?
One in five Medicare recipients currently uses medical marijuana. read more >
by Associated Press -
US Proposes Once-a-Year COVID Shots for Most Americans
The FDA will ask its panel of outside vaccine experts to weigh in at a meeting Thursday. read more >
by Associated Press -
FDA Change Ushers in Cheaper, Easier-To-Get Hearing Aids
Before over-the-counter, you usually needed to get your hearing tested and buy hearing aids from a specialist. That's no longer the case. read more >
by Associated Press -
Drug Slows Alzheimer’s, but Can it Make a Real Difference?
The trial is important because it shows a drug that attacks a sticky protein called amyloid -- considered one of several culprits behind Alzheimer's -- can delay disease progression. read more >
by Associated Press -
FDA Pushes to Remove Pregnancy Drug, Company Pushes Back
Health regulators insist Covis Pharma's product doesn't work. read more >
by Associated Press -
Sign up for Daily E-news
Sign Up
THIS WEEK’S EDITION
This Week’s Stories
View Digital Edition
